Sodium–glucose transporter-2 inhibitors for prevention and treatment of cardiorenal complications of type 2 diabetes

Sodium–glucose transporter-2 inhibitors for prevention and treatment of cardiorenal complications of type 2 diabetes

Abstract Hospitalization for major diabetes complications, including myocardial infarction, stroke, lower-extremity amputation, and end-stage kidney disease, is on the rise and represents a great health burden for patients with type 2 diabetes (T2D), in particular for older people. Newer glucose-low...

Full description

Bibliographic Details
Main Authors: Dario Giugliano, Miriam Longo, Lorenzo Scappaticcio, Paola Caruso, Katherine Esposito
Format: Article
Language:English
Published: BMC 2021-01-01
Series:Cardiovascular Diabetology
Subjects:
SGLT-2 inhibitors
Type 2 diabetes
MACE
Heart failure
Diabetic kidney disease
Age
Online Access:https://doi.org/10.1186/s12933-021-01213-w

Internet

https://doi.org/10.1186/s12933-021-01213-w

Similar Items